Investing in Life Science Innovation

TVM Capital Life Science is one of the transatlantic Venture Capital pioneers with teams based in North America and Europe.

Learn more

Home
About Us
Team
Senior Advisors
Portfolio
News
Events
ESG Policy
Contact

Main Content

Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update

November 22, 2021

Kent Imaging – Setting A New Global Standard in Advanced Tissue Assessment

November 16, 2021

Nekonal and TVM Capital Life Science Announce Creation of T7 Therapeutics to Develop Innovative Therapy for Patients with Auto-immune diseases

November 16, 2021

Footer

About Us

We are creating sustainable value – for patients, the pharmaceutical industry and our investors. Since 1984, TVM Capital Life Science has invested in more than 130 life science companies in Europe, Canada and the United States, currently managing in excess of €900 million from more than 50 investors.

Our Team

TVM Capital Life Science operates with an integrated team from its offices in Montreal and Munich. Our mission is to invest in the development of exciting life science products and the growth of substantial companies in the field that are or aspire to be innovative leaders in their market segment.

Offices

TVM Capital GmbH
Munich, Germany

TVM Life Science Management GmbH
Munich, Germany

TVM Life Science Management Inc.
Montreal, Westmount, Canada

Member of

in